ATE409705T1 - Pre-s-protein von hepatitis-b-virus (hbv) als adjuvans und komponente eines hbv-impfstoffs - Google Patents

Pre-s-protein von hepatitis-b-virus (hbv) als adjuvans und komponente eines hbv-impfstoffs

Info

Publication number
ATE409705T1
ATE409705T1 AT02771774T AT02771774T ATE409705T1 AT E409705 T1 ATE409705 T1 AT E409705T1 AT 02771774 T AT02771774 T AT 02771774T AT 02771774 T AT02771774 T AT 02771774T AT E409705 T1 ATE409705 T1 AT E409705T1
Authority
AT
Austria
Prior art keywords
hbv
vaccine
virus
hepatitis
adjuvant
Prior art date
Application number
AT02771774T
Other languages
English (en)
Inventor
Hong-Mo Moon
Ki-Yong Kim
Jung-Sun Yum
Byung-Cheol Ahn
Su-Young Yi
Young Seomun
Ji-Hee Park
Original Assignee
Dobeel Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dobeel Corp filed Critical Dobeel Corp
Application granted granted Critical
Publication of ATE409705T1 publication Critical patent/ATE409705T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C07K14/395—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT02771774T 2001-05-25 2002-05-02 Pre-s-protein von hepatitis-b-virus (hbv) als adjuvans und komponente eines hbv-impfstoffs ATE409705T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR20010029002 2001-05-25

Publications (1)

Publication Number Publication Date
ATE409705T1 true ATE409705T1 (de) 2008-10-15

Family

ID=19709949

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02771774T ATE409705T1 (de) 2001-05-25 2002-05-02 Pre-s-protein von hepatitis-b-virus (hbv) als adjuvans und komponente eines hbv-impfstoffs

Country Status (7)

Country Link
US (1) US20040137016A1 (de)
EP (1) EP1390397B1 (de)
KR (1) KR100587944B1 (de)
AT (1) ATE409705T1 (de)
DE (1) DE60229126D1 (de)
ES (1) ES2315405T3 (de)
WO (1) WO2002094866A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8748373B2 (en) * 2007-02-21 2014-06-10 Fox Chase Cancer Center Hepatitis B virus compositions and methods of use
ES2784189T3 (es) 2009-03-27 2020-09-23 Academia Sinica Métodos y composiciones para la inmunización contra virus
WO2012146630A1 (en) 2011-04-29 2012-11-01 F. Hoffmann-La Roche Ag N-terminal acylated polypeptides, methods for their production and uses thereof
SI3204030T1 (sl) * 2014-10-07 2022-10-28 Myr Gmbh Kombinirano zdravljenje okužbe s HBV in HDV
EP4021923A1 (de) * 2019-08-29 2022-07-06 VIR Biotechnology, Inc. Hepatitis-b-virus-impfstoffe

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4847080A (en) * 1984-03-07 1989-07-11 New York Blood Center, Inc. Pre-S gene coded peptide hepatitis B immunogens, vaccines, diagnostics, and synthetic lipide vesicle carriers
US4816564A (en) * 1986-01-31 1989-03-28 Merck & Co., Inc. Method for producing hepatitis B virus proteins in yeast
JPS62236496A (ja) * 1986-04-07 1987-10-16 Green Cross Corp:The ＨＢｓＡｇの製造方法

Also Published As

Publication number Publication date
DE60229126D1 (de) 2008-11-13
WO2002094866A1 (en) 2002-11-28
EP1390397A1 (de) 2004-02-25
KR100587944B1 (ko) 2006-06-08
EP1390397B1 (de) 2008-10-01
ES2315405T3 (es) 2009-04-01
US20040137016A1 (en) 2004-07-15
KR20040018379A (ko) 2004-03-03

Similar Documents

Publication Publication Date Title
AU6616301A (en) Modification of hepatitis b core antigen
DK1090033T4 (da) Partikler af HCV-kappeproteiner: Anvendelse til vaccination
BG98523A (en) Hla-limited cytotoxic t-lymphocytic (ctl) epitopes of the virus of hepatite b
DK1296711T3 (da) HPV-E7 til behandling af humant papillomavirus
ATE402715T1 (de) Hcv-impfstoff zusammensetzungen
AP1771A (en) 3'-Prodrugs of 2'-deoxy-?-L-nucleosides.
ATE327246T1 (de) Hepatitis c tripeptid inhibitoren
DE60324552D1 (en) Substituierte cycloalkyl p1' hepatitis c virus inhibitoren
EP1200109A4 (de) Verwendung von peptid-nukleinsäureverbindungen zur auslösung zellulärer immunantworten gegen hepatitis c
IS7533A (is) Lifrarbólgu C-veirutálmar
DK1362109T3 (da) Rekombinante oligomere protein-komplekser med foröget immunogent potentiale
EA200701869A1 (ru) Пептидомиметические ингибиторы протеазы
MX2009000650A (es) Vacunas para malaria.
NO20050396L (no) Adjuvant viral partikkel
MXPA02011545A (es) Virus del sindrome respiratorio y reproductor porcino (peesv), vacuna recombinante para el virus de la viruela.
DE69130071D1 (de) Zusammensetzung verwendbar als therapeutisches mittel gegen chronische virale leberkrankheiten
MXPA03006971A (es) Tratamiento del virus de hepatitis b.
EA200300129A1 (ru) Очистка антигенов вируса гепатита b (hbv) для применения в вакцинах
ATE473997T1 (de) Zur bildung von partikeln fähiges hbv-precore- protein
ATE409705T1 (de) Pre-s-protein von hepatitis-b-virus (hbv) als adjuvans und komponente eines hbv-impfstoffs
EP1572721A4 (de) Prävention und behandlung von hcv-infektionen unter anwendung von gegen konformationelle und lineare epitope gerichteten antikörpern
RU2313363C2 (ru) Очищенные белки оболочки вируса гепатита с для диагностического и терапевтического применения
MX2007002659A (es) Composicion vacunal contra el virus de la hepatitis c.
DE69814884D1 (de) Hepatitis b virale polypeptide
RU2004104357A (ru) Вакцинный состав, потенцированный комбинацией днк и антигена

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties